CNTN - Hillstream BioPharma Inc.

3.41
0.040   1.173%

Share volume: 285,141
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$3.37
0.04
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
39%
Profitability 35%
Dept financing 35%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.94%
1 Month
7.57%
3 Months
-5.01%
6 Months
10.36%
1 Year
150.74%
2 Year
-37.20%
Key data
Stock price
$3.41
P/E Ratio 
0.00
DAY RANGE
$3.31 - $3.48
EPS 
-$6.70
52 WEEK RANGE
$1.08 - $9.08
52 WEEK CHANGE
$150.74
MARKET CAP 
13.164 M
YIELD 
N/A
SHARES OUTSTANDING 
35.045 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
-0.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$494,954
AVERAGE 30 VOLUME 
$647,049
Company detail
CEO: Randy D. Milby
Region: US
Website: hillstreambio.com
Employees: 2
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Hillstream BioPharma, Inc. develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) The company was incorporated in 2019 and is based in Bridgewater, New Jersey.

Recent news